1,3-dicapryloylglycerol has been researched along with 1-oleoyl-2-acetylglycerol in 1 studies
Studies (1,3-dicapryloylglycerol) | Trials (1,3-dicapryloylglycerol) | Recent Studies (post-2010) (1,3-dicapryloylglycerol) | Studies (1-oleoyl-2-acetylglycerol) | Trials (1-oleoyl-2-acetylglycerol) | Recent Studies (post-2010) (1-oleoyl-2-acetylglycerol) |
---|---|---|---|---|---|
8 | 0 | 0 | 626 | 0 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murthy, M; Rao, GH; Reddy, S | 1 |
1 other study(ies) available for 1,3-dicapryloylglycerol and 1-oleoyl-2-acetylglycerol
Article | Year |
---|---|
1,3-Dioctanoylglycerol (1,3-DiC8) is as effective as 1,2-dioctanoylglycerol (1,2-DiC8) in priming phospholipase A2 activation in human platelets and neutrophils.
Topics: Arachidonic Acid; Blood Platelets; Calcimycin; Diglycerides; Enzyme Activation; Humans; Neutrophils; Phospholipases A; Phospholipases A1; Phospholipases A2; Protein Kinase C; Tetradecanoylphorbol Acetate | 1994 |